Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery
This study has been terminated.
Study NCT00967447
Information provided by Boehringer Ingelheim Pharmaceuticals
First Received on August 13, 2009.
Last Updated on February 13, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
